Article
FDA OKs New Keytruda Shot for Cancer
Bearish
-50.0
−100 Bearish
0
+100 Bullish
Merck says an injected version of its blockbuster infusion Keytruda is quicker and easier. But it stands to slow the adoption of cheaper competitors, increasing costs by billions of dollars.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Source
New York Times Business
Published
Sep 19, 2025 · 6:29 pm
Article ID
91902391003889876481
Original URL
Open source
Sentiment Signal
Bearish
-50.0
−100Neutral+100
More Like This